COST-EFFECTIVENESS OF DENOSUMAB VS. ZOLEDRONIC ACID IN A POPULATION 75 YEARS OR OLDER IN THE US

被引：0
|
作者：
Stolshek, Brad [1 ]
Kruse, Morgan [2 ]
Yurgin, Nicole [3 ]
Huang, Joice [4 ]
Ho, Pei-Ran [4 ]
Wang, Andrea [4 ]
Parthan, Anju [2 ]
Taylor, Doug [2 ]
机构：
[1] Amgen Inc, Cambridge, England
[2] OptumInsight, Eden Prairie, MN USA
[3] Amgen Inc, Global Hlth Econ, Thousand Oaks, CA 91320 USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S137 / S138
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF DENOSUMAB VS. BRAND OR GENERIC ZOLEDRONIC ACID IN PATIENTS WITH BREAST CANCER IN KAZAKHSTAN
    Bektur, C.
    Nurgozhin, T.
    VALUE IN HEALTH, 2014, 17 (07) : A773 - A773
  • [2] Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
    Takahiro Mori
    Carolyn J. Crandall
    Tomoko Fujii
    David A. Ganz
    Archives of Osteoporosis, 2021, 16
  • [3] Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
    Mori, Takahiro
    Crandall, Carolyn J.
    Fujii, Tomoko
    Ganz, David A.
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [4] COST-EFFECTIVENESS COMPARISON OF DENOSUMAB AND ZOLEDRONIC ACID IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Ding, Y.
    Hay, J.
    VALUE IN HEALTH, 2014, 17 (03) : A47 - A47
  • [5] STUDY OF COST-EFFECTIVENESS AND BUDGETARY IMPACT OF DENOSUMAB VS. ZOLEDRONIC ACID FOR THE HANDLING OF BONE METASTASES IN PATIENTS WITH PROSTATE CANCER IN COLOMBIA
    Perez, M.
    Garcia Perlaza, J.
    Fletscher, P. M.
    Vargas-Valencia, J.
    VALUE IN HEALTH, 2017, 20 (09) : A876 - A876
  • [6] Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
    You, Ruxu
    Liu, Jinyu
    Ke, Lei
    Wan, Min
    Zhang, Yu
    Yu, Guangyi
    Mori, Takahiro
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases
    Kaitlin Koo
    Kinsey Lam
    Nicole Mittmann
    Andre Konski
    Kristopher Dennis
    Liang Zeng
    Henry Lam
    Edward Chow
    Supportive Care in Cancer, 2013, 21 : 1785 - 1791
  • [8] Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases
    Xie, Jipan
    Diener, Melissa
    Sorg, Rachael
    Wu, Eric Q.
    Namjoshi, Madhav
    CLINICAL BREAST CANCER, 2012, 12 (04) : 247 - 258
  • [9] Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases
    Koo, Kaitlin
    Lam, Kinsey
    Mittmann, Nicole
    Konski, Andre
    Dennis, Kristopher
    Zeng, Liang
    Lam, Henry
    Chow, Edward
    SUPPORTIVE CARE IN CANCER, 2013, 21 (06) : 1785 - 1791
  • [10] The Population Impact and Cost-Effectiveness of Blood Pressure Treatment in US Adults Age 75 and Older
    Odden, Michelle C.
    Coxson, Pamela
    Moran, Andrew
    Guzman, David
    Goldman, Lee
    Bibbins-Domingo, Kirsten
    HYPERTENSION, 2013, 62 (03)
12345